Cargando…

Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis

BACKGROUND: The medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy [MRONJ (BP)] is characterized by non-healing exposed bone in the maxillofacial region. The pathogenesis of MRONJ (BP) is not fully understood. Giant, hypernucleated, inactive osteoclasts were found in MRO...

Descripción completa

Detalles Bibliográficos
Autores principales: Gross, Christian, Weber, Manuel, Creutzburg, Kay, Möbius, Patrick, Preidl, Raimund, Amann, Kerstin, Wehrhan, Falk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461625/
https://www.ncbi.nlm.nih.gov/pubmed/28587628
http://dx.doi.org/10.1186/s12967-017-1230-8
_version_ 1783242372536074240
author Gross, Christian
Weber, Manuel
Creutzburg, Kay
Möbius, Patrick
Preidl, Raimund
Amann, Kerstin
Wehrhan, Falk
author_facet Gross, Christian
Weber, Manuel
Creutzburg, Kay
Möbius, Patrick
Preidl, Raimund
Amann, Kerstin
Wehrhan, Falk
author_sort Gross, Christian
collection PubMed
description BACKGROUND: The medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy [MRONJ (BP)] is characterized by non-healing exposed bone in the maxillofacial region. The pathogenesis of MRONJ (BP) is not fully understood. Giant, hypernucleated, inactive osteoclasts were found in MRONJ (BP) tissues, which indicated that accelerated cell–cell fusion might play a role. Dendritic cell-specific transmembrane protein (DC-STAMP) is associated with the cell–cell fusion of osteoclasts and precursor cells. Tartrate-resistant acid phosphatase (TRAP) is essential for osteoclastic bone resorption. The cell–cell fusion, as part of the osteoclastogenesis, and the resorptive activity can determine the morphology of osteoclasts. This study analyzed jaw bone from patients with MRONJ (BP), osteomyelitis (OM) and osteoradionecrosis (ORN) because a comparison with the osteoclast profiles of OM and ORN is essential for characterizing the osteoclast profile of MRONJ (BP). METHODS: Formalin-fixed routine jaw bone specimens from 70 patients [MRONJ (BP) n = 30; OM: n = 15, ORN: n = 15, control: n = 10] were analyzed retrospectively for osteoclast quantity, morphology and the expression of TRAP and DC-STAMP. The specimens were processed for hematoxylin and eosin staining (H&E), histochemistry (TRAP) and immunohistochemistry (anti-DC-STAMP) and were analyzed via virtual microscopy. RESULTS: The quantity, diameter and nuclearity of osteoclasts were significantly higher in MRONJ (BP) specimens than in OM, ORN and control specimens. Giant, hypernucleated osteoclasts were detected in MRONJ (BP) specimens only. Osteoclastic TRAP expression was lower in MRONJ (BP) and ORN specimens than in OM and control specimens. The DC-STAMP expression of osteoclasts and mononuclear cells was significantly higher in MRONJ (BP) and ORN specimens than in OM and control specimens. CONCLUSIONS: This study indicates that the osteoclast profile of MRONJ (BP) is characterized by osteoclast inactivation and a high cell–cell fusion rate; however, the presence of giant, hypernucleated osteoclasts cannot be attributed to increased DC-STAMP-triggered cell–cell fusion alone. The incidental characterization of the osteoclast profiles of OM and ORN revealed differences that might facilitate the histopathological differentiation of these diseases from MRONJ (BP), which is essential because their therapies are somewhat different.
format Online
Article
Text
id pubmed-5461625
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54616252017-06-07 Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis Gross, Christian Weber, Manuel Creutzburg, Kay Möbius, Patrick Preidl, Raimund Amann, Kerstin Wehrhan, Falk J Transl Med Research BACKGROUND: The medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy [MRONJ (BP)] is characterized by non-healing exposed bone in the maxillofacial region. The pathogenesis of MRONJ (BP) is not fully understood. Giant, hypernucleated, inactive osteoclasts were found in MRONJ (BP) tissues, which indicated that accelerated cell–cell fusion might play a role. Dendritic cell-specific transmembrane protein (DC-STAMP) is associated with the cell–cell fusion of osteoclasts and precursor cells. Tartrate-resistant acid phosphatase (TRAP) is essential for osteoclastic bone resorption. The cell–cell fusion, as part of the osteoclastogenesis, and the resorptive activity can determine the morphology of osteoclasts. This study analyzed jaw bone from patients with MRONJ (BP), osteomyelitis (OM) and osteoradionecrosis (ORN) because a comparison with the osteoclast profiles of OM and ORN is essential for characterizing the osteoclast profile of MRONJ (BP). METHODS: Formalin-fixed routine jaw bone specimens from 70 patients [MRONJ (BP) n = 30; OM: n = 15, ORN: n = 15, control: n = 10] were analyzed retrospectively for osteoclast quantity, morphology and the expression of TRAP and DC-STAMP. The specimens were processed for hematoxylin and eosin staining (H&E), histochemistry (TRAP) and immunohistochemistry (anti-DC-STAMP) and were analyzed via virtual microscopy. RESULTS: The quantity, diameter and nuclearity of osteoclasts were significantly higher in MRONJ (BP) specimens than in OM, ORN and control specimens. Giant, hypernucleated osteoclasts were detected in MRONJ (BP) specimens only. Osteoclastic TRAP expression was lower in MRONJ (BP) and ORN specimens than in OM and control specimens. The DC-STAMP expression of osteoclasts and mononuclear cells was significantly higher in MRONJ (BP) and ORN specimens than in OM and control specimens. CONCLUSIONS: This study indicates that the osteoclast profile of MRONJ (BP) is characterized by osteoclast inactivation and a high cell–cell fusion rate; however, the presence of giant, hypernucleated osteoclasts cannot be attributed to increased DC-STAMP-triggered cell–cell fusion alone. The incidental characterization of the osteoclast profiles of OM and ORN revealed differences that might facilitate the histopathological differentiation of these diseases from MRONJ (BP), which is essential because their therapies are somewhat different. BioMed Central 2017-06-06 /pmc/articles/PMC5461625/ /pubmed/28587628 http://dx.doi.org/10.1186/s12967-017-1230-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gross, Christian
Weber, Manuel
Creutzburg, Kay
Möbius, Patrick
Preidl, Raimund
Amann, Kerstin
Wehrhan, Falk
Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
title Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
title_full Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
title_fullStr Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
title_full_unstemmed Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
title_short Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
title_sort osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461625/
https://www.ncbi.nlm.nih.gov/pubmed/28587628
http://dx.doi.org/10.1186/s12967-017-1230-8
work_keys_str_mv AT grosschristian osteoclastprofileofmedicationrelatedosteonecrosisofthejawsecondarytobisphosphonatetherapyacomparisonwithosteoradionecrosisandosteomyelitis
AT webermanuel osteoclastprofileofmedicationrelatedosteonecrosisofthejawsecondarytobisphosphonatetherapyacomparisonwithosteoradionecrosisandosteomyelitis
AT creutzburgkay osteoclastprofileofmedicationrelatedosteonecrosisofthejawsecondarytobisphosphonatetherapyacomparisonwithosteoradionecrosisandosteomyelitis
AT mobiuspatrick osteoclastprofileofmedicationrelatedosteonecrosisofthejawsecondarytobisphosphonatetherapyacomparisonwithosteoradionecrosisandosteomyelitis
AT preidlraimund osteoclastprofileofmedicationrelatedosteonecrosisofthejawsecondarytobisphosphonatetherapyacomparisonwithosteoradionecrosisandosteomyelitis
AT amannkerstin osteoclastprofileofmedicationrelatedosteonecrosisofthejawsecondarytobisphosphonatetherapyacomparisonwithosteoradionecrosisandosteomyelitis
AT wehrhanfalk osteoclastprofileofmedicationrelatedosteonecrosisofthejawsecondarytobisphosphonatetherapyacomparisonwithosteoradionecrosisandosteomyelitis